46,814 Shares in Tilray Inc (NASDAQ:TLRY) Bought by Rpo LLC

Rpo LLC acquired a new stake in shares of Tilray Inc (NASDAQ:TLRY) during the fourth quarter, Holdings Channel reports. The fund acquired 46,814 shares of the company’s stock, valued at approximately $62,000. Tilray comprises about 0.1% of Rpo LLC’s portfolio, making the stock its 25th biggest position.

Several other hedge funds also recently added to or reduced their stakes in TLRY. BNP Paribas Financial Markets lifted its position in shares of Tilray by 1,314.1% during the third quarter. BNP Paribas Financial Markets now owns 1,819,494 shares of the company’s stock worth $3,202,000 after purchasing an additional 1,690,827 shares during the last quarter. Point72 Asset Management L.P. acquired a new stake in Tilray during the third quarter valued at approximately $1,348,000. Atria Wealth Solutions Inc. lifted its holdings in Tilray by 174.7% during the 4th quarter. Atria Wealth Solutions Inc. now owns 84,516 shares of the company’s stock worth $112,000 after buying an additional 53,751 shares during the last quarter. Arizona State Retirement System grew its position in shares of Tilray by 9.9% in the 4th quarter. Arizona State Retirement System now owns 261,233 shares of the company’s stock worth $347,000 after acquiring an additional 23,439 shares in the last quarter. Finally, Swiss National Bank increased its holdings in shares of Tilray by 10.2% in the 4th quarter. Swiss National Bank now owns 1,776,638 shares of the company’s stock valued at $2,363,000 after acquiring an additional 164,600 shares during the last quarter. 9.35% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Separately, Canaccord Genuity Group lifted their price objective on shares of Tilray from $2.00 to $3.00 and gave the stock a “buy” rating in a report on Monday, January 13th. Three equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $2.70.

Tilray Trading Down 0.6 %

NASDAQ:TLRY opened at $0.65 on Thursday. The firm has a market capitalization of $609.48 million, a P/E ratio of -2.17 and a beta of 1.88. The business has a 50 day simple moving average of $0.82 and a 200 day simple moving average of $1.24. The company has a debt-to-equity ratio of 0.10, a current ratio of 2.54 and a quick ratio of 1.58. Tilray Inc has a 12-month low of $0.58 and a 12-month high of $2.97.

Tilray (NASDAQ:TLRY) last announced its quarterly earnings results on Friday, January 10th. The company reported ($0.10) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.03) by ($0.07). Tilray had a negative net margin of 30.95% and a negative return on equity of 4.40%. The firm had revenue of $210.90 million for the quarter, compared to analyst estimates of $216.34 million. Tilray’s revenue for the quarter was up 8.7% compared to the same quarter last year. Equities research analysts predict that Tilray Inc will post -0.2 EPS for the current year.

About Tilray

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.